← Eichor
Study identifier: NCT05644522 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Nomad P-KAFO Study

Condition: Cerebrovascular Accident · Post-polio Syndrome · Spinal Cord Injuries  ·  Sponsor: Shirley Ryan AbilityLab

PhaseNA
Planned participants36
Who can joinAll sexes, 18 Years to 89 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to evaluate the impact of using the Nomad powered KAFO in people who have had a musculoskeletal or neurological injury that has affected their ability to walk. The main questions it aims to answer are to quantify the effectiveness of the Nomad in improving mobility, balance, frequency of falls, and quality of life in individuals with lower-extremity impairments compared to their own brace, over three months of daily home and community use. Participants will: * Wear a sensor that records everyday activities and mobility. * Perform measures of mobility and different activities of participation using their own brace. * Perform measures of mobility and different activities of participation using the Nomad powered KAFO

This description comes directly from the study's public registry record.

Talk to the study team

Arun Jayaraman, PhD  ·  312-238-6875  ·  ajayaraman@sralab.org

Always discuss trial participation with your own doctor first.

Locations (1)

Shirley Ryan AbilityLabChicago, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05644522